After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Cerus Corp is listed on the NASDAQ in the Healthcare sector while operating in the Medical Devices industry. The current market capitalization of Cerus Corp is $254.96M. A total of 0.94 million shares were traded on the day, compared to an average of 1.18M shares.
In the most recent transaction, Gregory Dean A. bought 25,000 shares of CERS for 1.25 per share on Aug 25 ’25. After the transaction, the Director now owns 86,725 company shares. In a previous transaction on Mar 14 ’25, Jensen Chrystal sold 30,075 shares at 1.45 per share. CERS shares that Chief Legal Officer owns now total 783,294.
Among the insiders who sold shares, Jensen Chrystal disposed of 18,949 shares on Mar 13 ’25 at a per-share price of $1.45. This resulted in the Chief Legal Officer holding 813,369 shares of CERS after the transaction. In another insider transaction, Jayaraman Vivek K sold 46,004 shares at $1.45 per share on Mar 14 ’25. Company shares held by the Chief Operating Officer now total 1,431,326.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CERS has a high of $2.23 and a low of $1.12.
As of this writing, CERS has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.03. The company reported an EPS of -$0.02 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CERS’s latest balance sheet shows that the firm has $129.36M in Cash & Short Term Investments as of fiscal 2021. There were $87.59M in debt and $78.56M in liabilities at the time. Its Book Value Per Share was $0.29, while its Total Shareholder’s Equity was $85.62M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CERS is Buy with a score of 4.20.
